Genentech reviews

3.9

74% would recommend to a friend

(552 total reviews)
avatar

Ashley Magargee

83% approve of CEO

55% positive business outlook

Reviews by job title

552 reviews

Reviews about "Compensation"

Return to all reviews
4.0
Jan 24, 2026
Recommend
CEO approval
Business Outlook

Pros

Decent salary, good benefits, semi-flexible schedule.

Cons

Constantly working at near burn-out level. Roche insists on standardizing EVERYTHING globally, creating a constant feeling of change. Job security is not what it used to be.

4.0
Jan 14, 2026
Recommend
CEO approval
Business Outlook

Pros

Healthy location, excellent benefits, smart colleagues, robust pipeline

Cons

too many middle managers, slows down pragmatic decision making, IT infrastructure are not cohesive or talking to each other. antiquated performance review system that has not changed in decades -

avatar
Genentech Response
3mo
Thank you for your feedback and input. We recognize that being a large and complex company sometimes results in lengthier processes, and we continue to work on streamlining these to incorporate more agility into the way we work whenever possible. Regarding your concerns about transformation, within the context of an evolving healthcare landscape, we are evaluating our operations to ensure we remain well-positioned to deliver on our pipeline of new medicines for patients. We understand that adjustments in process can be difficult at times, and we are grateful for the contributions our teams make during these periods.
Viewing 16 - 18 of 552 Reviews

Glassdoor has 5,071 Genentech reviews submitted anonymously by Genentech employees. Read employee reviews and ratings on Glassdoor to decide if Genentech is right for you.